71 related articles for article (PubMed ID: 27461616)
1. Correlations between gastric cancer family history and ROBO2 and RASSF2A gene methylations.
Chang ZW; Dong L; Qin YR; Song M; Guo HY; Zhu QL
J Cancer Res Ther; 2016; 12(2):597-600. PubMed ID: 27461616
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer.
Maruyama R; Akino K; Toyota M; Suzuki H; Imai T; Ohe-Toyota M; Yamamoto E; Nojima M; Fujikane T; Sasaki Y; Yamashita T; Watanabe Y; Hiratsuka H; Hirata K; Itoh F; Imai K; Shinomura Y; Tokino T
Carcinogenesis; 2008 Jul; 29(7):1312-8. PubMed ID: 18310659
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
[TBL] [Abstract][Full Text] [Related]
4. Methylation of DLEC1 promoter is a predictor for recurrence in Chinese patients with gastric cancer.
Ye X; Feng G; Jiao N; Pu C; Zhao G; Sun G
Dis Markers; 2014; 2014():804023. PubMed ID: 25574068
[TBL] [Abstract][Full Text] [Related]
5. Relationship between methylation status of RASSF2A gene promoter and endometriosis-associated ovarian cancer.
Xia Y; Xiong N; Huang Y
J Biol Regul Homeost Agents; 2018; 32(1):21-28. PubMed ID: 29504361
[TBL] [Abstract][Full Text] [Related]
6. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G
Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
[TBL] [Abstract][Full Text] [Related]
11. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
12. Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability.
Je EM; Gwak M; Oh H; Choi MR; Choi YJ; Lee SH; Yoo NJ
Pathology; 2013 Dec; 45(7):645-50. PubMed ID: 24247621
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma.
Hibi K; Sakata M; Yokomizo K; Kitamura YH; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2009 Dec; 29(12):5053-5. PubMed ID: 20044616
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
[TBL] [Abstract][Full Text] [Related]
16. RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer.
Li Z; Chang X; Dai D; Deng P; Sun Q
Oncol Rep; 2014 Apr; 31(4):1661-8. PubMed ID: 24573726
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers.
Sugai T; Habano W; Endoh M; Konishi Y; Akasaka R; Toyota M; Yamano H; Koeda K; Wakabayashi G; Suzuki K
Int J Cancer; 2010 Dec; 127(11):2500-9. PubMed ID: 20178104
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancer.
Goto T; Mizukami H; Shirahata A; Yokomizo K; Kitamura YH; Sakuraba K; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2010 Jul; 30(7):2701-3. PubMed ID: 20683001
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
Jin J; Xie L; Xie CH; Zhou YF
Genet Mol Res; 2014 May; 13(2):4140-5. PubMed ID: 24938706
[TBL] [Abstract][Full Text] [Related]
20. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
